Immunohistochemical staining data from the Human Protein Atlas showed that 100% and 55% of examined colon cancer patients exhibited high and medium BAP1 expression levels, respectively, depending on the source of the antibodies used (Fig. 1A). Here, BAP1 is linked to malignant colon neoplasm.